Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ABEO vs BZFD: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
ABEO Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–3 Matrix Metrics)
ABEO Overall Winner
6-Pillar Tally: ABEO 3 – 3 BZFD
Matrix Metrics: ABEO 7 – 3 BZFD
As of Nov 20, 2026, Abeona Therapeutics Inc. (ABEO) is the stronger overall head-to-head candidate over BuzzFeed, Inc. (BZFD) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). ABEO carries a Unified Composite Score of 49.9/100 (HOLD) at $2.42 (18.7x Forward P/E, -186.1% operating margin), whereas BZFD carries 51.3/100 (HOLD) at $0.38 (N/M Forward P/E, -17.7% operating margin).
- Composite vs. Pillar Nuance: While BZFD currently prints a higher short-term Unified Composite Score (51.3/100 HOLD vs. ABEO 49.9/100 HOLD), ABEO captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (-186.1% vs. -17.7% operating margin) and revenue trajectory (+2745.0% vs. -43.8% YoY).
- Technical & Structure Timing Caution: ABEO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 26.6); meanwhile BZFD is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 25.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About ABEO vs BZFD
ABEO
Head-to-Head Winner
Abeona Therapeutics Inc. Common Stock
$2.42
-1.22% 1D
Market Cap
$167.4M
TTM Revenue
$39M
Forward P/E
18.7x
Beta / 30D Vol
0.60β · 149% Vol
Unified Composite Score
49.9
HOLD
Tech 60.0
Fund 61.0
Flow 67.0
Mom 55.0
Weinstein Technical Phase
Markdown · Sell / avoid
BZFD
BuzzFeed, Inc. Class A Common Stock
$0.38
+2.79% 1D
Market Cap
$38.1M
TTM Revenue
$150M
Forward P/E
N/M
Beta / 30D Vol
2.52β · 192% Vol
Unified Composite Score
51.3
HOLD
Tech 55.0
Fund 52.0
Flow 60.0
Mom 55.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (ABEO 3 – 3 BZFD)
1. Valuation Multiples
ABEO
Forward P/E
18.7x
N/M
Trailing P/E
18.7x
N/M
PEG Ratio
N/M
N/M
EV / Revenue
3.0x
0.5x
2. Growth & Scale
ABEO
Revenue Growth (YoY)
+2745.0%
-43.8%
Earnings Growth (YoY)
+0.0%
-54.7%
TTM Revenue (USD)
$39M
$150M
Market Cap
$167.4M
$38.1M
3. Profitability & Quality
BZFD
Gross Margin
-3.5%
40.5%
Operating Margin
-186.1%
-17.7%
Net Profit Margin
-160.3%
-48.0%
Return on Equity (ROE)
-42.1%
-123.0%
4. Balance Sheet & Cash Flow
BZFD
Cash Generation (TTM)
-$66M
-$39M
Cash Flow Margin
N/A
-26.2%
Net Cash / Leverage
$50M Net Cash
$39M Net Debt (1.18x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
ABEO
Options Structure Phase
BREAKDOWN
BREAKDOWN
Current IV / %ile
165.8% (27th %ile)
319.8% (50th %ile)
Put/Call OI Skew
0.26x (Call-Skewed)
N/A
OBV Trend / Tech Phase
NEUTRAL · Markdown
NEUTRAL · Markdown
6. R&D & Supply-Chain Moat
BZFD
OpEx & R&D Intensity
N/A
58.2% of Rev ($88M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Biotechnology Operator
Internet Content & Information Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: ABEO (7) vs BZFD (3)| Institutional Metric | ABEO | BZFD | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $167.4M | $38.1M | ABEO | |
| Trailing P/E Ratio | 18.7x | N/M | ABEO | |
| Forward P/E Ratio | 18.7x | N/M | ABEO | |
| Revenue Growth (YoY) | +2745.0% | -43.8% | ABEO | |
| Operating Margin (TTM) | -186.1% | -17.7% | BZFD | |
| Net Profit Margin | -160.3% | -48.0% | BZFD | |
| Return on Equity (ROE) | -42.1% | -123.0% | ABEO | |
| 52-Week Range Position | 6% ($2–$8) | 2% ($0–$2) | ABEO | |
| Beta / 30D Volatility | 0.60β · 149% Vol | 2.52β · 192% Vol | ABEO | |
| Unified Institutional Score | 49.9 / 100 (HOLD) | 51.3 / 100 (HOLD) | BZFD | |
| Trailing 12M Revenue (USD) | $39M | $150M | Scale | |
| Gross Profit Margin (TTM) | -3.5% | 40.5% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 3.0x EV/Rev | N/M PEG · 0.5x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$66M ($50M Net Cash) | -$39M ($39M Net Debt (1.18x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
ABEO +15.45 pp
3M Horizon
ABEO +6.72 pp
6M Horizon
ABEO +26.53 pp
1Y Horizon
ABEO +17.63 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ABEO Revenue | BZFD Revenue | ABEO Op. Margin | BZFD Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $0M | N/A | -1940.2% | N/A | ABEO |
| FY2019 | N/A | $320M | N/A | -12.7% | BZFD |
| FY2020 | $10M | $320M | -814.2% | 3.8% | BZFD |
| FY2021 | $0M | $380M | -2994.5% | -6.2% | BZFD |
| FY2022 | $0M | $330M | -3600.8% | -35.2% | BZFD |
| FY2023 | $0M | $230M | -1346.7% | -19.5% | BZFD |
| FY2024 | N/A | $190M | N/A | -12.4% | BZFD |
| FY2025 | $10M | $190M | -1536.9% | -25.8% | BZFD |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
ABEO
BREAKDOWN
Current IV
165.8%
IV Percentile
27th %ile
Put/Call OI Skew
0.26x (Call-Skewed)
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact ABEO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
BZFD
BREAKDOWN
Current IV
319.8%
IV Percentile
50th %ile
Put/Call OI Skew
N/A
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact BZFD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
ABEO Moat Profile
Cyclical / Execution-Driven Positioning
Biotechnology Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
BZFD Moat Profile
Cyclical / Execution-Driven Positioning
Internet Content & Information Operator
OpEx & R&D Reinvestment
58.2% of Rev ($88M)
90D Engineering Disclosures
0 Published
Investor FAQ ABEO vs BZFD Key Questions & Quantitative Answers
As of Nov 20, 2026, Abeona Therapeutics Inc. (ABEO) is the stronger overall head-to-head candidate over BuzzFeed, Inc. (BZFD) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). ABEO carries a Unified Composite Score of 49.9/100 (HOLD) at $2.42 (18.7x Forward P/E, -186.1% operating margin), whereas BZFD carries 51.3/100 (HOLD) at $0.38 (N/M Forward P/E, -17.7% operating margin). Composite vs. Pillar Nuance: While BZFD currently prints a higher short-term Unified Composite Score (51.3/100 HOLD vs. ABEO 49.9/100 HOLD), ABEO captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (-186.1% vs. -17.7% operating margin) and revenue trajectory (+2745.0% vs. -43.8% YoY). Technical & Structure Timing Caution: ABEO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 26.6); meanwhile BZFD is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 25.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ABEO leads the Growth & Scale pillar: ABEO posts +2745.0% YoY revenue growth and +0.0% YoY earnings growth on $39M TTM revenue (-3.5% gross margin, -186.1% operating margin), compared with BZFD at -43.8% YoY revenue growth and -54.7% YoY earnings growth on $150M TTM revenue (40.5% gross margin, -17.7% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), ABEO cumulative revenue shifted +0.0% while BZFD shifted -40.6%. In operating R&D and SG&A reinvestment, ABEO deploys N/A (0 90-day corporate R&D disclosures) versus 58.2% of Rev ($88M) (0 disclosures) for BZFD.
ABEO screens cheaper on headline valuation multiples. ABEO trades at 18.7x Forward P/E, 18.7x Trailing P/E, N/M PEG, and 3.0x EV/Revenue (unreported FCF margin), whereas BZFD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-26.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABEO (-42.1% ROE) versus BZFD (-123.0% ROE) capital efficiency.
In options market volatility and institutional positioning, ABEO carries 165.8% implied volatility (27th %ile, Balanced (25th–60th %ile)), a 0.26x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.60β · 149% Vol realized risk). By comparison, BZFD carries 319.8% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (2.52β · 192% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
BZFD vs ABEO · Reverse Pair
ABEO vs ABUS
· Sector Peer
ABEO vs VSTM
· Sector Peer
BZFD vs MSGM
· Sector Peer
BZFD vs AKAN
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma